WHO ICTRP trial
Efficacy and safety of Pediatric Huanglong Granule in children with attention…
ChiCTR2300069926 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2300069926 |
|---|---|
| Public title | Efficacy and safety of Pediatric Huanglong Granule in children with attention deficit hyperactivity disorder: study protocol for a randomized, double-blind, placebo-controlled, multicenter clinical trial |
| Scientific title | Efficacy and safety of Pediatric Huanglong Granule in children with attention deficit hyperactivity disorder: study protocol for a randomized, double-blind, placebo-controlled, multicenter clinical trial |
| Primary sponsor | Dongzhimen Hospital, Beijing University of Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Attention deficit hyperactivity disorder |
| Interventions | Treatment Group:Pediatric Huanglong Granule;Control Group:Pediatric Huanglong Granule Placebo |
| Registration date | Mar 29, 2023 |
| Target size | Treatment Group:160;Control Group:80 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: